Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
31 participants
INTERVENTIONAL
2013-11-30
2016-02-29
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Determinants of the Effectiveness of Robot-assisted Hand Movement Training
NCT04818073
Robot-Assisted Hand Motor Therapy for Subjects With Hemiparetic Stroke
NCT01244243
Robot-assisted Therapy Combined With Mirror Priming in Upper Limb Training in Stroke
NCT04326140
To Determine the Therapeutic Effect of the Music Glove and Conventional Hand Exercises to Subacute Stroke Patients
NCT02410629
Study of Hand Therapy 3 to 24 Months After Stroke
NCT00435617
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
FINGER I
Subjects participate in 3 weeks of exercising with the experimental device: FINGER robot with first setting at a minimum of 3 days per week, 1 hour per day with the exercise program
FINGER I
FINGER is a robot that measures finger movements and allows patients to play computer game using those movements. Patients will be exercising with FINGER using setting I
FINGER II
FINGER is a robot that measures finger movements and allows patients to play computer game using those movements. Patients will be exercising with FINGER using setting II
FINGER II
Subjects participate in 3 weeks of exercising with the experimental device: FINGER robot with a second setting at a minimum of 3 days per week, 1 hour per day with the exercise program
FINGER I
FINGER is a robot that measures finger movements and allows patients to play computer game using those movements. Patients will be exercising with FINGER using setting I
FINGER II
FINGER is a robot that measures finger movements and allows patients to play computer game using those movements. Patients will be exercising with FINGER using setting II
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
FINGER I
FINGER is a robot that measures finger movements and allows patients to play computer game using those movements. Patients will be exercising with FINGER using setting I
FINGER II
FINGER is a robot that measures finger movements and allows patients to play computer game using those movements. Patients will be exercising with FINGER using setting II
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Have history of stroke affecting the arm, at least 6 months prior to enrollment
* have arm and/or hand weakness as measured on a standard clinical scale
* do not have active major psychological problems, or problems affecting the stroke-affected arm or hand besides the stroke
* do not have active major brain disease other than the stroke
* have absence of pain in the stroke-affected arm and hand
Exclusion Criteria
* severe problems speaking or understanding speech as measured on a standard clinical scale
* severe reduced level of consciousness
* severe loss ability to sense movement of your limbs as measured on a standard clinical scale
* currently pregnant
* difficulty in understanding or complying with the instructions given by the researcher
* inability to perform the experimental task that will be studied
* increased pain with movement of the stroke-affected arm or hand
* Subjects having any implanted metal such as metallic splinters, metallic surgical clips, prosthetic heart valves, pacemakers, neuro-stimulation devices, orthodontic work that contains ferromagnetic materials,
* Subjects whose occupation or activities may cause accidental lodging of ferromagnetic materials, or that may have imbedded metal fragments from military activities, unless cleared by a screening head CT scan
* Subjects with tattoo(s) presenting metallic or ferromagnetic color ingredients or with facial make-up
* Subjects who have claustrophobia
* Subjects who are currently pregnant or breastfeeding.
18 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of California, Irvine
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
David Reinkensmeyer
Professor of Anatomy and Neurobiology
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
David Reinkensmeyer, PhD
Role: PRINCIPAL_INVESTIGATOR
University of California, Irvine
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of California, Irvine
Irvine, California, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Ingemanson ML, Rowe JR, Chan V, Wolbrecht ET, Reinkensmeyer DJ, Cramer SC. Somatosensory system integrity explains differences in treatment response after stroke. Neurology. 2019 Mar 5;92(10):e1098-e1108. doi: 10.1212/WNL.0000000000007041. Epub 2019 Feb 6.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HS#2008-6432
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.